Dilated cardiomyopathy induced by anti-tumor necrosis factor

Int J Cardiol. 2009 Feb 6;132(1):e26-7. doi: 10.1016/j.ijcard.2007.07.109. Epub 2007 Nov 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Cardiomyopathy, Dilated / chemically induced*
  • Female
  • Humans
  • Infliximab
  • Middle Aged
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab